Amotl2 was described with a dual tumour suppressive function by targeting both Yap (known as anti‐apoptosis transcription factor) and Akt (which contributes to impaired apoptosis in cancer) (Han et al., 2017). This evidence concerns the gene AKT1 and cancer.